Harrow to Announce Fourth Quarter 2022 Financial Results on March 23, 2023

by Business Wire • 2023/03/02 • 0 Comments

NASHVILLE, Tenn.--(BUSINESS WIRE)---- $HROW--Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced that it will release its financial results for the fourth quarter and year ended December 31, 2022, on Thursday, March 23, 2023, after the market close. The Company will also post its fourth quarter Letter to Stockholders to the “Investors” section of its website, harrow.com. Harrow will host a conference call and live webcast at 4:45 p.m. Eastern Time to discuss the results

← Bay Area Retina Associates (BARA) Offers the First-Ever FDA-Approved Treatment for Geographic Atrophy (GA), the Advanced Dry Form of Age-Related Macular Degeneration (AMD)

Visus Therapeutics to Attend TD Cowen’s 43rd Annual Health Care Conference →

Post navigation